This episode of MedTech Global Insights delves into the critical process of FDA medical device registration, the essential first step for entering the lucrative U.S. market. We break down the three core regulatory pathways—510(k), Premarket Approval (PMA), and De Novo—and explore the strategic decisions that determine success or failure. Navigating this landscape is fraught with potential missteps. Choosing an incorrect pathway or failing to provide sufficient evidence can result in years of delays and millions in wasted capital, jeopardizing a product's launch. This episode provides the foundational knowledge to help you build a robust and efficient regulatory strategy. A prime example is a medical imaging startup with a novel AI-powered diagnostic software. They pursued a 510(k) assuming their software was similar to existing imaging analysis tools. However, the FDA determined their AI's autonomous decision-making capability represented a new level of risk with no clear predicate, leading to a rejection. This forced a costly and time-consuming pivot to a De Novo submission, a delay that could have been avoided with a more nuanced upfront analysis of the device's novelty and risk profile. Key Takeaways: - What are the critical differences between the 510(k), PMA, and De Novo pathways? - How do you select a "substantially equivalent" predicate device for a 510(k) submission and avoid common pitfalls? - When is the rigorous and data-intensive PMA pathway unavoidable for your device? - For a truly novel technology, how do you determine if the De Novo pathway is the right strategic choice? - What are the most common reasons the FDA rejects submissions? - Beyond the main application, what are the essential administrative duties like establishment registration and device listing? - How can you proactively budget for MDUFA user fees to avoid financial surprises? - Why could a pre-submission meeting with the FDA be the most important meeting you take? For more information, contact us at [email protected] or visit https://pureglobal.com/